Concordia International Corp. | Key People and Executives
Randall C. Benson
Director
Francis I. Perier
Independent Non-Executive Director
Patrick Volkert Vink
Independent Non-Executive Director
Rochelle Fuhrmann
Independent Non-Executive Director
Douglas N. Deeth
Independent Non-Executive Director
Graeme Duncan
Chief Executive Officer
Karl Ian Belk
Chief Operating Officer
Adeel Ahmad
Chief Financial Officer
Guy Clark
Chief Corporate Development Officer
Randall C. Benson
Director
Adam Peeler
Vice President-Investor Relations & Communications
Francesco Tallarico
Secretary & Chief Legal Officer
Francis I. Perier
Independent Non-Executive Director
Patrick Volkert Vink
Independent Non-Executive Director
Rochelle Fuhrmann
Independent Non-Executive Director
Douglas N. Deeth
Independent Non-Executive Director
| Address |
277 Lakeshore Road East
Oakville Ontario L6H 1J9
Canada
|
|
Employees
|
- |
| Website |
http://www.concordiarx.com |
| Updated |
09/14/2018 |
| Concordia International Corp. is a pharmaceutical company, which engages in owning and licensing a diversified portfolio of branded and generic prescription products. It operates through the Concordia North America and Concordia International segments. The Concordia North America segment focuses primarily on the United States pharmaceutical market and offers products under the brand of Donnatal, Zonegran, Nilandron, Lanoxin, Plaquenil, and Photofrin. |
